BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Liang Y, Si X. Hydroxamic acid hybrids as the potential anticancer agents: An Overview. European Journal of Medicinal Chemistry 2020;205:112679. [DOI: 10.1016/j.ejmech.2020.112679] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Lorca M, Cabezas D, Araque I, Terán A, Hernández S, Mellado M, Espinoza L, Mella J. Cancer and brassinosteroids: Mechanisms of action, SAR and future perspectives. Steroids 2023;190:109153. [PMID: 36481216 DOI: 10.1016/j.steroids.2022.109153] [Reference Citation Analysis]
2 Rahman ML, Sarjadi MS, Sarkar SM, Walsh DJ, Hannan JJ. Poly(hydroxamic acid) resins and their applications. Coordination Chemistry Reviews 2022;471:214727. [DOI: 10.1016/j.ccr.2022.214727] [Reference Citation Analysis]
3 Mikra C, Melissari Z, Kokotou MG, Gritzapis P, Fylaktakidou KC. Microwave-assisted synthesis of hydroxamic acid incorporated quinazolin-4[3H]-one derivatives. Sustainable Chemistry and Pharmacy 2022;29:100772. [DOI: 10.1016/j.scp.2022.100772] [Reference Citation Analysis]
4 Korkmaz IN, Özdemir H. Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents. Appl Biochem Biotechnol 2022. [PMID: 35917102 DOI: 10.1007/s12010-022-04107-z] [Reference Citation Analysis]
5 Jakubkiene V, Valiulis GE, Schweipert M, Zubriene A, Matulis D, Meyer-almes F, Tumkevicius S. Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids. Beilstein J Org Chem 2022;18:837-44. [DOI: 10.3762/bjoc.18.84] [Reference Citation Analysis]
6 Yang Z, Zhou Z, Luo X, Luo X, Luo H, Luo L, Yang W. Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity. Molecules 2021;27:220. [PMID: 35011453 DOI: 10.3390/molecules27010220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sochacka-Ćwikła A, Mączyński M, Regiec A. FDA-Approved Drugs for Hematological Malignancies-The Last Decade Review. Cancers (Basel) 2021;14:87. [PMID: 35008250 DOI: 10.3390/cancers14010087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Yang L, Zhang W, Qiu Q, Su Z, Tang M, Bai P, Si W, Zhu Z, Liu Y, Yang J, Kuang S, Liu J, Yan W, Shi M, Ye H, Yang Z, Chen L. Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity. J Med Chem 2021;64:15379-401. [PMID: 34648295 DOI: 10.1021/acs.jmedchem.1c01451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lauria A, La Monica G, Bono A, Martorana A. Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets. Eur J Med Chem 2021;220:113555. [PMID: 34052677 DOI: 10.1016/j.ejmech.2021.113555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Teli G, Chawla PA. Hybridization of Imidazole with Various Heterocycles in Targeting Cancer: A Decade's Work. ChemistrySelect 2021;6:4803-36. [DOI: 10.1002/slct.202101038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hou S, Diez J, Wang C, Becker-Pauly C, Fields GB, Bannister T, Spicer TP, Scampavia LD, Minond D. Discovery and Optimization of Selective Inhibitors of Meprin α (Part I). Pharmaceuticals (Basel) 2021;14:203. [PMID: 33671080 DOI: 10.3390/ph14030203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhang XH, Qin-Ma, Wu HP, Khamis MY, Li YH, Ma LY, Liu HM. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity. J Med Chem 2021;64:1362-91. [PMID: 33523672 DOI: 10.1021/acs.jmedchem.0c01782] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 17.0] [Reference Citation Analysis]
13 Xiao J, Gao M, Sun Z, Diao Q, Wang P, Gao F. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Eur J Med Chem 2020;208:112830. [PMID: 32992133 DOI: 10.1016/j.ejmech.2020.112830] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]